Second ethical comments towards COVID-19 (one year later)

Cover Page

Cite item

Abstract

At the beginning of COVID-19 development, when social vulnerability in the face of the global infectious threat became obvious, we presented target information on a key civilizational issue — the role of ethics in epidemic emergencies. The compliance of RF legislation and the world ethical standards analyzed on based on the study of the humanitarian heritage of pandemic management and a review of existing international documents. Today, one year later, it is time to practically evaluate the effectiveness of the ideology of ethical commitment and objectively comprehend the conflicts that have arisen, their causes and consequences. It should be emphasized that this work is not a so-called “moral lesson learned from COVID-19”, but representation of a real picture of how the centuries-old experience of former epidemics and pandemics was taken into account and the unique truth of the ethical content of management decisions and actions was accepted. It is particularly important to have a possibility to present this article as a continuation of our research topic on the bioethics of pandemics, on the pages of such an authoritative, specialized journal, which fully allows us to preserve the integrity of ideas about the humanitarian essence of anti-epidemic measures. This humanitarian parallel starts from the moment of managing a particular patient with infectious pathology until large-scale measures for eradication vaccine-preventable diseases. A comprehensive and dynamic look at the need to find ways and the nature of overcoming ethical conflicts during the ongoing pandemic of the new coronavirus infection could determine the ethical approach of longterm recommendations in the field of public health protection and ensure the stability of social trust in the future.

About the authors

O. I. Kubar

St. Petersburg Pasteur Institute

Author for correspondence.
Email: okubar@list.ru

Olga I. Kubar - PhD, MD (Medicine), Professor; Leading Researcher, Department of Etiology and Control of Viral Infections, Member of the Russian Committee on Bioethics, Commission of the Russian Federation for UNESCO, Ministry of Foreign Affairs of the Russian Federation, ex-member of the UNESCO International Committee on Bioethics.

197101, St. Petersburg, Mira str., 14

Russian Federation

M. A. Bichurina

St. Petersburg Pasteur Institute

Email: romanenkova@pasteurorg.ru

PhD, MD (Medicine), Head of Laboratory of Etiology and Control of Virus Infections and WHO Subnational Laboratories for Poliomyelitis, Measles and Rubella.

St. Petersburg

Russian Federation

N. I. Romanenkova

St. Petersburg Pasteur Institute

Email: romanenkova@pasteurorg.ru

Romanenkova N.I., PhD (Medicine), Leading Researcher of the Laboratory of Etiology and Control of Virus Infections and WHO Subnational Laboratory for Poliomyelitis.

St. Petersburg

Russian Federation

References

  1. Болдырев О. В России обсуждают высокую смертность от COVID-19 среди врачей // BBC News: русская служба. Июнь 2020. URL: https://www.bbc.com/russian/features-53094577 (01.02.2021)
  2. В России подтверждено только 40 смертей врачей от COVID-19 // Коммерсантъ: новости. Июль, 2020. URL: https://www.kommersant.ru/doc/4400147 (01.02.2021)
  3. Илесанми М.А. Пандемии и проблемы ограничения прав человека // Юрист. 2018. № 8. С. 59—65. doi: 10.18572/18123929-2018-8-59-65
  4. Кодекс надлежащей практики Ассоциации международных фармацевтических производителей (AIPM). М.: 2019. 128 c. URL: http://www.aipm.org/netcat_files/80/124/h_864109e0706201bd75c7a9196bb350cd
  5. Козкина А., Френкель Д., Литаврин М., Шулаев Н. В России от коронавируса погибли не менее 186 медиков — смертность среди них в 16 раз выше, чем в других странах // Медиазона. Май, 2020. URL: https://yandex.ru/turbo/zona.media/s/article/2020/05/19/martyro-logy (01.02.2021)
  6. Колбин А.С., Белоусов Д.Ю., Гомон Ю.М., Балыкина Ю.Е., Иванов И.Г. Социально-экономическое бремя COVID-19 в Российской Федерации // Качественная клиническая практика. 2020. № 1. С. 35—44. doi: 10.37489/2588-0519-2020-1-35-44
  7. Кубарь О.И. Этический комментарий к COVID-2019 // Инфекция и иммунитет. 2020. Т. 10, № 2. С. 287-294. [Kubar O.I. Ethical comments on COVID-19. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2020, vol. 10, no. 2, pp. 287294. (In Russ.)] doi: 10.15789/2220-7619-ECO-1447
  8. Кубарь О.И., Бичурина М.А., Романенкова Н.И., Асатрян А.Ж. Этические принципы ликвидации инфекций // Инфекция и иммунитет. 2013. Т. 3, № 3. С. 205-212. doi: 10.15789/2220-7619-2013-3-205-212
  9. Международные медико-санитарные правила (2005 г.). 3-е изд. ВОЗ, 2016. 92 с. [International health regulations (2005). 3rd ed. WHO, 2016. 92 p. (In Russ.)] URL: https://www.who.int/ihr/publications/9789241580496/ru
  10. Микиртичан Г.Л. Исторический аспект этико-правовых отношений в инфекционной патологии. В кн.: Этика инфекционной патологии / Под общ. ред. О.И. Кубарь. СПб.: ФБУН НИИЭМ имени Пастера, 2014. С. 8-40.
  11. О временном ограничении въезда в РФ иностранных граждан и лиц без гражданства, в том числе прибывающих с территории Республики Беларусь, а также граждан Республики Беларусь: распоряжение Правительства РФ от 16 марта 2020 г. № 635-р. URL: https://base.garant.ru/73751180
  12. О чрезвычайном положении: Федеральный конституционный закон от 30.05.2001 № 3-ФКЗ (ред. от 03.07.2016). URL: http://www.consultant.ru/document/cons_doc_LAW_31866
  13. Почему выгорают врачи. Хроника необъявленной волны COVID-19 в регионах России // Новая газета. Октябрь, 2020. URL: https://novayagazeta.ru/articles/2020/10/11/87470-pochemu-vygorayut-vrachi (01.02.2021)
  14. Сырочкина М.А. Этика продвижения вакцин. В кн.: Этика инфекционной патологии / Под общ. ред. О.И. Кубарь. СПб.: ФБУН НИИЭМ имени Пастера, 2014. С. 138-144.
  15. Хохлов А.Л., Полозова Е.А., Комисарова В.А., Чудова Н.В., Цызман Л.Г. Риски, сопряженные с этическими аспектами проведения клинических исследований // Качественная клиническая практика. 2020. № 1. С. 61—68. doi: 10.37489/2588-05192020-1-61-68
  16. Этика инфекционной патологии. Под общ. ред. О.И. Кубарь. СПб.: ФБУН НИИЭМ имени Пастера, 2014. 116 с.
  17. Adams J.G., Walls R.M. Supporting the health care workforce during the COVID-19 global epidemic. JAMA, 2020, vol. 323, no. 15, pp. 1439-1440. doi: 10.1001/jama.2020.3972
  18. Clinical ethics recommendations for admission to intensive care and for withdrawing treatment in exceptional conditions of imbalance between needs and available resources. Italian Society for Anaesthesia, Analgesia, Resuscitation, and Intensive Care. March 13, 2020.
  19. COVID-19: obstetrics care centers for disease prevention and control. considerations for infection prevention and control of coronavirus disease 2019 (COVID-19) in inpatient obstetric healthcare settings. May 20, 2020. URL: https://www.cdc.gov/coronavirus/2019-ncov/hcp/inpatient-obstetric-healthcare-guidance.html (01.02.2021)
  20. Ethical guidelines in pandemic influenza, CDC. Atlanta (USA): 2007. 12 p.
  21. Ethical issues in pandemic influenza planning. World Health Organization. URL: http://www.who.int/ethics/influenza_project/en (01.02.2021)
  22. Gostin L.O., Hodge J.G. Reforming federal public health powers: responding to national and global threats. JAMA, 2017, vol. 317, no. 12, pp. 1211-1212. doi: 10.1001/jama.2017.1021
  23. Gostin L.O., Hodge J.D. US Emergency Legal Responses to Novel Coronavirus. Balancing Public Health and Civil Liberties. JAMA, 2020, vol. 323, no. 12, pp. 1131-1132. doi: 10.1001/jama.2020.2025
  24. Guidance on the management of clinical trials during the COVID-19 (Coronavirus) pandemic. Version 3 (28/04/2020). Brussels: 2020. 21 p. URL: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/guidanceclinicaltrials_covid19_en.pdf
  25. Hick J.L., Hanfling D., Wynia M.K., Andrew T. Duty to plan: health care, crisis standards of care, and novel coronavirus SARS-CoV-2. NAM Perspectives, 2020, doi: 10.31478/202003b
  26. Khan K., Eckhardt R., Brownstein J.S., Naqvi R., Hu W., Kossowsky D., Scales D., Arino J., MacDonald M., Wang J., Sears J., Cetron M.S. Entry and exit screening of airline travelers during the A(H1N1) 2009 pandemic: a retrospective evaluation. Bulletin of the World Health Organization, 2013, vol. 91, no. 1-6, pp. 368-376.
  27. Kubar O.I., Bichurina M.A., Romanenkova N.I. Ethical consideration regarding COVID-19. EC Microbiol., special iss., 2020, pp. 14-15.
  28. Stand on guard for thee. Ethical considerations in preparedness planning for pandemic influenza. A report of the University of Toronto Joint Centre for Bioethics. Toronto: 2005. 27p.
  29. Stockpiling antivirals for pandemic influenza: the key ethical principles. Prepared by Ethics Subcommittee of the Advisory Committee to the Director. CDC. November 28, 2007.
  30. Whelan A., Young G., Catanese V.M. Medical students and patients with COVID-19: education and safety considerations. March 5, 2020. Washington: American association of medical colleges, 2020. URL: https://www.umassmed.edu/globalassets/office-of-commu-nications/documents/role-of-medical-students-and-covid-191.pdf
  31. WHO remains firmly committed to the principles set out in the preamble to the Constitution. URL: https://www.who.int/about/who-we-are/constitution (01.02.2021)

Copyright (c) 2021 Kubar O.I., Bichurina M.A., Romanenkova N.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies